Sygnus Biotech Logo
KOZINUS CREAM
Rx Only
Ready for 24-48h Central Dispatch
In Stock

KOZINUS CREAM Clinical Monograph & Batch COA

Certified DCGI Formulation Literature (PDF)

Download
Cream & OintmentPrescription Required (Schedule Drug)

KOZINUS CREAM

5.0(1 review)
Verified Quality Batch
Active Drug Composition

Kojic Acid, Dipalmetate, Vitamin E, Vitamin C, Arbutin, L-Glutathione

WHO-GMP Certified Batch ManufacturingDCGI Approved Formulation100% BioavailableAlu-Alu Packaging

KOZINUS CREAM (Kojic Acid, Dipalmetate, Vitamin E, Vitamin C, Arbutin, L-Glutathione) is manufactured under strict WHO-GMP compliance for maximum bioavailability and therapeutic efficacy.

Dosage FormCream
Packaging Presentation30gm
B2B Distributor & Healthcare Professional Notice:This product is supplied solely through verified licensed pharmaceutical distributors, stockists, and institutional tenders. Online retail checkout for prescription formulations is legally restricted.

Clinical Pharmacology & Therapeutic Profile

Comprehensive therapeutic guidelines for medical practitioners and institutional procurement

Therapeutic Indications

Indicated for therapeutic management within specified clinical indications under qualified physician guidance.

Mechanism of Action (MOA)

The active pharmacological principles in KOZINUS CREAM deliver targeted therapeutic action through standardized systemic bioavailability and verified pharmacodynamics.

Dosage & Posology

As directed by the registered medical practitioner. Strictly adhere to full course duration.

Safety & Precautions

Well tolerated under clinical supervision. Contraindicated in patients with hypersensitivity to active ingredients.

Storage Guidelines

Store in a cool place below 25°C. Do not freeze. Replace cap tightly after use.

WHO-GMP Certified Purity

Manufactured in state-of-the-art HVAC controlled cleanrooms with 100% active ingredient bio-potency and analytical batch testing.

Alu-Alu Moisture Barrier

Superior barrier protection against tropical humidity, preventing physical degradation and guaranteeing 24-month stability.

Exclusive District Monopoly

Strict PCD franchise monopoly allocation ensuring zero price competition and complete territory protection for our partners.

Technical Product Specifications

Therapeutic SegmentCream & Ointment
Dosage FormCream
Packaging Type30gm
Regulatory ScheduleSchedule H
Country of OriginIndia
Quality StandardWHO-GMP & ISO 9001:2015
Batch Analytical COASupplied with Trade Invoice

Active Medical Composition

KOZINUS CREAM features Kojic Acid, Dipalmetate, Vitamin E, Vitamin C, Arbutin, L-Glutathione prepared to high pharmaceutical purity standards.

Therapeutic ClassificationCream & Ointment
Regulatory ScheduleSchedule Drug (Prescription Only)

*Disclaimer: Formulations are intended solely for distribution to licensed practitioners, hospitals, and pharmacies. Dosage must adhere to medical advice.

Verified Practitioner & Distributor Feedback

Customer & Clinical Reviews

Real feedback from registered physicians, stockists, PCD franchise partners, and verified buyers.

5.0

Based on 1 verified review

5
1 (100%)
4
0 (0%)
3
0 (0%)
2
0 (0%)
1
0 (0%)
Verified Feedback
28 Aug 2026

Endorsed by attending medical offic for KOZINUS CREAM

KOZINUS CREAM has been endorsed by attending medical officers for dependable recovery, offering predictable therapeutic action that doctors in our territory rely upon daily. Sturdy outer cartons and individual pack serialization facilitate seamless inventory scanning. Continues to be a key prescription driver in our PCD pharma franchise portfolio.

Dr. B. K. Rathore•Consultant Diabetologist & General Physician, Indore
Distributor Inquiries

Questions Regarding KOZINUS CREAM

What is the therapeutic indication and composition of KOZINUS CREAM?

KOZINUS CREAM contains Kojic Acid, Dipalmetate, Vitamin E, Vitamin C, Arbutin, L-Glutathione indicated for Indicated for therapeutic management within specified clinical indications under qualified physician guidance. as formulated by Sygnus Biotech.

What packaging presentations are available for KOZINUS CREAM?

KOZINUS CREAM is supplied in tamper-evident 15g / 30g Laminated Aluminum Barrier Tube, engineered with barrier foil protection to ensure a 24 to 36 month shelf life.

Is monopoly PCD franchise territory available for KOZINUS CREAM?

Yes, Sygnus Biotech grants exclusive district-wise monopoly marketing rights for KOZINUS CREAM along with promotional visual aids, product cards, and marketing support.

What is the regulatory schedule and minimum order quantity (MOQ)?

KOZINUS CREAM is categorized as Schedule H with an introductory PCD franchise MOQ of 100 units per batch.

Related Formulations in Cream & Ointment

View all Cream & Ointment →
Cream & Ointment
TRIPCEE

TRIPCEE

Clobetasol 0.05% w/w , Neomycin 0.1% w/w , Miconazole 2% w/w

Pack:20gm
Cream & Ointment
VIVO+ GEL

VIVO+ GEL

Diclofenac Sodium 1% w/v + Linseed Oil 3% w/w + Methyl Salicylate 10% w/w +Capsaicin 0.025% w/w Menthol 5% w/w + Benzyl Alcohol 1% w/w

Pack:30gm
Cream & Ointment
OXIDINE TOOTH PASTE

OXIDINE TOOTH PASTE

Pottasium Nitrate + Sodium Monofluorophosphate + Triclosan

Pack:50gm
Cream & Ointment
ACNEGO ADVANCE CREAM

ACNEGO ADVANCE CREAM

Hydroquinone 2% w/w + Tretinoin 0.025% w/w + Mometasone Furoate 0.1% w/w

Pack:15gm
Monopoly PCD Franchise

Apply for Exclusive Marketing Rights of KOZINUS CREAM

Check vacant territory availability in your state or district. Enjoy full marketing kit support, visual aids, and guaranteed zero competitor supply.